151 related articles for article (PubMed ID: 8490898)
21. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03.
Hyams DM; Mamounas EP; Petrelli N; Rockette H; Jones J; Wieand HS; Deutsch M; Wickerham L; Fisher B; Wolmark N
Dis Colon Rectum; 1997 Feb; 40(2):131-9. PubMed ID: 9075745
[TBL] [Abstract][Full Text] [Related]
22. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
23. Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.
Nabhan C; Ragam A; Samuels B; Milton DT; Prasad L; Hooberman A; Hartsell W; Anthony A; Weisman R; Bitran JD
Clin Colorectal Cancer; 2007 Mar; 6(6):436-41. PubMed ID: 17531107
[TBL] [Abstract][Full Text] [Related]
24. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
[TBL] [Abstract][Full Text] [Related]
26. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma.
Grann A; Feng C; Wong D; Saltz L; Paty PP; Guillem JG; Cohen AM; Minsky BD
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):987-95. PubMed ID: 11240239
[TBL] [Abstract][Full Text] [Related]
27. Pelvic radiotherapy with concurrent 5-fluorouracil modulated by leucovorin for rectal cancer: a phase II study.
Cooper SG; Bonaventura A; Ackland SP; Joseph DJ; Stewart JF; Hamilton CS; Denham JW
Clin Oncol (R Coll Radiol); 1993; 5(3):169-73. PubMed ID: 8347540
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W
Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775
[TBL] [Abstract][Full Text] [Related]
29. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.
Hoff PM; Janjan N; Saad ED; Skibber J; Crane C; Lassere Y; Cleary KR; Benner S; Randolph J; Abbruzzese JL; Pazdur R
J Clin Oncol; 2000 Oct; 18(20):3529-34. PubMed ID: 11032595
[TBL] [Abstract][Full Text] [Related]
30. Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer.
Minsky BD; Cohen AM; Enker WE; Kelsen DP; Kemeny N; Riechman B; Saltz L; Sigurdson ER; Frankel J
Int J Radiat Oncol Biol Phys; 1992; 22(1):139-45. PubMed ID: 1727111
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcome of interstitial pulsed dose rate brachytherapy in multimodality treatment of locally advanced primary or recurrent rectal and sigmoid cancer with high risk of incomplete microscopic resection.
Nielsen MB; Rasmussen PC; Tanderup K; Nielsen SK; Fokdal L; Laurberg S; Lindegaard JC
Acta Oncol; 2016 Dec; 55(12):1408-1413. PubMed ID: 27537776
[TBL] [Abstract][Full Text] [Related]
32. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR
Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973
[TBL] [Abstract][Full Text] [Related]
33. Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer.
Minsky BD; Conti JA; Huang Y; Knopf K
J Clin Oncol; 1995 Jun; 13(6):1409-16. PubMed ID: 7751886
[TBL] [Abstract][Full Text] [Related]
34. Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience.
Lee WC; Yusof MM; Lau FN; Phua VC
Asian Pac J Cancer Prev; 2013; 14(6):3941-4. PubMed ID: 23886211
[TBL] [Abstract][Full Text] [Related]
35. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer.
Alektiar KM; Zelefsky MJ; Paty PB; Guillem J; Saltz LB; Cohen AM; Minsky BD
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):219-26. PubMed ID: 10924992
[TBL] [Abstract][Full Text] [Related]
36. Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: phase I-II study.
Landry JC; Koretz MJ; Wood WC; Bahri S; Smith RG; Costa M; Daneker GW; York MR; Sarma PR; Lynn M
Radiology; 1993 Aug; 188(2):423-6. PubMed ID: 8327689
[TBL] [Abstract][Full Text] [Related]
37. Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer.
Hu JB; Sun XN; Yang QC; Xu J; Wang Q; He C
World J Gastroenterol; 2006 Apr; 12(16):2610-4. PubMed ID: 16688811
[TBL] [Abstract][Full Text] [Related]
38. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.
Scheithauer W; Depisch D; Kornek G; Pidlich J; Rosen H; Karall M; Prochaska M; Ernst A; Sebesta C; Eckhardt S
Cancer; 1994 Mar; 73(6):1562-8. PubMed ID: 8156482
[TBL] [Abstract][Full Text] [Related]
39. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
[TBL] [Abstract][Full Text] [Related]
40. Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy.
Tsutsumi S; Tabe Y; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Shioya M; Saito J; Asao T; Nakano T; Kuwano H
Anticancer Res; 2011 Nov; 31(11):3963-7. PubMed ID: 22110227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
